Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.

BACKGROUND Diabetic nephropathy is the leading cause of kidney failure in the United States. The extent to which an elevated glycated hemoglobin (HbA(1c)) concentration is associated with increased risk of chronic kidney disease (CKD) in the absence of albuminuria and retinopathy, the hallmarks of diabetic nephropathy, is uncertain. METHODS Glycated hemoglobin concentration was measured in 1871 adults with diabetes mellitus followed up for 11 years in the Atherosclerosis Risk in Communities (ARIC) Study. Incident CKD was defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m(2) after 6 years of follow-up or a kidney disease-related hospitalization. We categorized HbA(1c) concentrations into 4 clinically relevant categories. Albuminuria and retinopathy were measured midway through follow-up. RESULTS Higher HbA(1c) concentrations were strongly associated with risk of CKD in models adjusted for demographic data, baseline glomerular filtration rate, and cardiovascular risk factors. Compared with HbA(1c) concentrations less than 6%, HbA(1c) concentrations of 6% to 7%, 7% to 8%, and greater than 8% were associated with adjusted relative hazard ratios (95% confidence intervals) of 1.4 (0.97-1.91), 2.5 (1.70-3.66), and 3.7 (2.76-4.90), respectively. Risk of CKD was higher in individuals with albuminuria and retinopathy, and the association between HbA(1c) concentration and incident CKD was observed even in participants without either abnormality: adjusted relative hazards, 1.46 (95% confidence intervals, 0.80-2.65), 1.17 (0.43-3.19), and 3.51 (1.67-7.40), respectively; P(trend) = .004. CONCLUSIONS We observed a positive association between HbA(1c) concentration and incident CKD that was strong, graded, independent of traditional risk factors, and present even in the absence of albuminuria and retinopathy. Hyperglycemia is an important indicator of risk of both diabetic nephropathy with albuminuria or retinopathy and of less specific forms of CKD.

[1]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[2]  B. Brenner,et al.  Brenner & Rector's the Kidney , 1996 .

[3]  K. Burns.  Angiotensin II and its receptors in the diabetic kidney. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  T. Köse,et al.  Alterations of blood pressure in type 1 diabetic children and adolescents , 2006, Pediatric Nephrology.

[5]  R. Klein,et al.  Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. , 1999, American journal of epidemiology.

[6]  L. Bouter,et al.  Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. , 2002, Kidney international.

[7]  Haifeng Guo,et al.  Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  D. Zeng,et al.  Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) Study. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[10]  P. Whelton,et al.  Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT , 1997 .

[11]  R. Little,et al.  Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. , 2005, Clinical chemistry.

[12]  M. Steffes,et al.  Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[13]  M. Mauer,et al.  Enhancing the predictive value of urinary albumin for diabetic nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[14]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[15]  Aesha Drozdowski,et al.  Standards of medical care in diabetes. , 2004, Diabetes care.

[16]  Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. , 1995, Kidney international.

[17]  R. Klein,et al.  Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study. , 2007, American journal of ophthalmology.

[18]  A. Folsom,et al.  Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction. , 2006, Journal of the American College of Cardiology.

[19]  W. Henrich,et al.  Chronic kidney disease: a risk factor for cardiovascular disease. , 2005, Cardiology clinics.

[20]  R. Klein,et al.  The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. , 2002, Ophthalmology.

[21]  Hassane Izzedine,et al.  Abnormal blood pressure circadian rhythm: a target organ damage? , 2006, International journal of cardiology.

[22]  M. Hanefeld,et al.  Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. , 2007, American journal of hypertension.

[23]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[24]  V. Basevi.  Standards of medical care in diabetes--2007. , 2009, Diabetes care.

[25]  Deeb N Salem,et al.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.

[26]  Quan Dong Nguyen,et al.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.

[27]  M. Cooper,et al.  Diabetic nephropathy: where hemodynamics meets metabolism. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[28]  R. Klein,et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. , 1999, Ophthalmology.

[29]  J. Ingelfinger,et al.  Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. , 1999, Kidney international.

[30]  R. Little.  Glycated Hemoglobin Standardization – National Glycohemoglobin Standardization Program (NGSP) Perspective , 2003, Clinical chemistry and laboratory medicine.

[31]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[32]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[33]  P. Whelton,et al.  Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. , 1997, JAMA.

[34]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[35]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[36]  D. Levy,et al.  Glycemic status and development of kidney disease: the Framingham Heart Study. , 2005, Diabetes care.

[37]  Y. Toya,et al.  A Possible Relationship of Nocturnal Blood Pressure Variability with Coronary Artery Disease in Diabetic Nephropathy , 2007, Clinical and experimental hypertension.

[38]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  V. Bellizzi,et al.  [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[40]  K. Wu,et al.  ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.

[41]  B. Afşar,et al.  Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus? , 2007, Blood pressure monitoring.

[42]  T. Berl.  American Society of Nephrology Presidential Address 2005. , 2006, Journal of the American Society of Nephrology : JASN.

[43]  T. Dubose.  American Society of Nephrology Presidential Address 2006: chronic kidney disease as a public health threat--new strategy for a growing problem. , 2007, Journal of the American Society of Nephrology : JASN.

[44]  R. Kronmal,et al.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.

[45]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[46]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[47]  A. Zanchetti,et al.  Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients , 2006, Journal of hypertension.

[48]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.